Consensus DexCom, Inc.

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2026-09-04 pm EDT			5-day change	1st Jan Change
87.90 ^USD	-2.02%		-3.22%	+32.44%

Aug. 24	Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing	MT
Aug. 13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT

Evolution of the Average Target: DexCom, Inc.

Evolution of the Target Price: DexCom, Inc.

Changes in Analyst Recommendations: DexCom, Inc.

b1a44dcfc66.CikKmOycYXpECxPwDHpi3pPbuIl3Qh7ek3wMFl3wh_o.fHxy6brWKyARZEm-XEwHveGiyMovCSaW8R10U26CtZhgRHzsm9UnEjA-Sg~85a44ba852e7a395831194493b876476

Analysts' recommendations: DexCom, Inc.

Aug. 13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
Aug. 04	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
Aug. 03	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
Aug. 03	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
Jul. 31	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
Jul. 31	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
Jul. 31	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
Jul. 31	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
Jul. 31	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
Jul. 31	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
Jul. 31	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
Jul. 31	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
Jul. 31	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
Jul. 31	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
Jul. 31	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
Jul. 31	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
Jul. 31	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
Jul. 31	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
Jul. 31	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
Jul. 31	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT
Jul. 31	Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating	MT
Jul. 31	BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating	MT
Jul. 31	Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating	MT
Jul. 31	Analyst recommendations: Apple, Baxter International, Dexcom, Flex, Humana, Stellantis…
Jul. 28	UBS Adjusts Price Target on DexCom to $96 From $95, Maintains Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	DEXCOM, INC.					+7.08%
	ABBOTT LABORATORIES					+10.96%
	MEDTRONIC PLC					+11.25%
	CENCORA, INC.					+11.59%
	HOYA CORPORATION					+27.04%
	BECTON, DICKINSON AND COMPANY					+5.91%
	MEDLINE INC.					+21.89%
	WEST PHARMACEUTICAL SERVICES, INC.					+19.05%
	TERUMO CORPORATION					+29.14%
	STERIS PLC					+17.16%
	Average					+16.11%
	Weighted average by Cap.					+13.63%